期刊文献+

肾移植患者FK506浓度与肝肾功能、血常规指标的关系 被引量:3

Relationship between FK506 Concentration and Results of Liver and Renal Function Routine Blood Test in Renal Transplant Patients
下载PDF
导出
摘要 目的 探讨肾移植患者体内他克莫司(FK506)浓度与肝肾功能、血常规的关系.方法 随机选取2011年3月~2012年12月肾移植患者50例,均相放大酶免疫法检测FK506血药浓度;用酶法检测AST,ALP,GGT,Urea,Cr,Glu,UA和ALT;全自动血液分析仪检测RBC,HB,WBC,LYM,NEU和MONO.结果 肾移植患者FK506不同浓度组间的AST,ALP,GGT,Urea,RBC,HB,WBC,LYM和NEU水平,差异有统计学意义,而Cr,Glu,UA,ALT和MONO水平,差异无统计学意义.结论 肾移植患者FK506的浓度可能影响机体内AST,ALP,GGT,Urea,RBC,HB,WBC,LYM和NEU的水平,而对Cr,Glu,UA,ALT和MONO的水平影响不大. Objective To investigate the relationship between the liver function, renal function,routine blood test and different blood concentration of FK506. Methods 50 cases of renal transplant patients were randomly selected in March 2011 to De-cember 2012. The FKS06 was detected by homogeneous amplification immunoassay; ALT, AST, ALP, GGT, UA, Glu, Cr and Urea were detected by Enzymatic. RBC,HB and WBC were detected by Automatic blood analyzer. Results There was signifieant difference between ALP, GGT, Urea, AST, RBC, HB, WBC, LYM and NEU in different FKS06 concentration groups of kidney transplant patients,There was no significant difference between Cr, ALT,GLU, UA and MONO in differ-ent FK506 concentration groups of kidney transplant patients. Conclusion The FKS06 concentration in kidney transplant patients would affect the level of ALP,GGT, Urea, AST,RBC, HB, WBC, LYM and NEU. However,it had little effects on the levels of Cr, ALT,GLU,UA and MONO.
出处 《现代检验医学杂志》 CAS 2013年第5期123-125,共3页 Journal of Modern Laboratory Medicine
关键词 他克莫司 肝功能 肾功能 血常规 FKS06 liver function renal function blood routine examination
  • 相关文献

参考文献4

  • 1马林,万元胜,陈东生.他克莫司的临床应用[J].药物流行病学杂志,2008,17(1):8-10. 被引量:9
  • 2Shapiro R. Low toxicity immunosuppressive protocols in renal transplantation[J]. The Keio Journal of Med- icine,2004,53(1) :18-22.
  • 3朱跃,李超志,李海波,冯鹏程,吴博益.肾移植术后肝功能异常的临床分析[J].实用肝脏病杂志,2006,9(3):142-143. 被引量:1
  • 4Yadav DK, Gera DN,Gumber MR, et al. Tacrolimus- induced severe cholestasis complicating renal trans- plantation[J]. Renal Failure, 2013,35 (5) : 735-737.

二级参考文献15

  • 1穆安娜.FK506在肝移植中的应用[J].激光杂志,2005,26(2):12-12. 被引量:1
  • 2申济奎,李辰.FK506对大鼠穿透性角膜移植排斥反应的免疫抑制作用[J].眼科研究,1996,14(4):217-219. 被引量:3
  • 3LAM PW, WACHS ME, SOMBERG KA, et al. Fibrosing cholestatic hepatitis in renal [J]. Transplantation, 1996,61 (2) : 378-381.
  • 4MUELLER EA, VIESS D, MELLEIN B, et al. Cyclosporine microemulsion formulation: Pharmacokinetic/pharmaoodynamic relationship [J]. Transplant Proc, 1998, 30(7):1694-1696.
  • 5HUTCHINSON IV. The mode of action of prograf(tacrolimus) and its significance for long,term graft survival[J]. New Horizons Kidney Transplant, 1997,1 : 22-26.
  • 6DHAR DK,NAGASUE N,KIMOTO T, et al. The salutary effect of FK506 in ischemia-reperfusion injury of thecanine liver [J]. Transplantation, 1992,54: 583-588.
  • 7ALLISON AC, EUGUI EM. Mycophenolate mofetil, a rationally desigened im munosuppressive drug [J]. Clin Transplant, 1993,7 : 96-98.
  • 8Alshaibani K, Nizamuddin N, Raza S, et al. University of Wisconsin versus Eurocollins solution for kidney preservation: analysis of clinical outcome [ J ]. Transplant Porc, 1998 ,30(7) :3681-3682
  • 9Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK506 and cyclosporine on short and long-term kidney graft survival[ J]. Transplantation, 1995,60( 12 ) : 1384
  • 10Squifflet JP , Van Hooff JP, Vanrenterghem Y. The Benelux experience with the combination of tacrolimus and mycophenolate mofetil[J]. Transplant proc, 1999,31 (7) :72.

共引文献8

同被引文献20

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部